FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Nothing melts our hearts like a health policy valentine. Readers made us swoon this season, writing poetic lines about prescription
Read MoreDon Thompson SACRAMENTO, Calif. — Drug overdose deaths in California state prisons rebounded to near record levels last year even
Read MoreA Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank
Read MoreAlternate-day modified fasting is put to the test for lifespan extension. Is it true that alternate-day calorie restriction prolongs life?
Read MoreActivists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS)
Read MoreLawmakers and regulators in Washington are starting to puzzle over how to regulate artificial intelligence in health care — and
Read MoreIn the battle to control health care costs, hospitals are deploying their political power to protect their bottom lines. The
Read MoreFebruary 12, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreEvery weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a
Read MoreEstados están invirtiendo miles de millones de dólares en un experimento de atención médica de alto riesgo: utilizar fondos ya
Read More